Yasser Kehail - Global Bioprocessing and Analytics Product Manager, GE Healthcare
Please note: The exhibit hall is not open following this talk. The exhibit hall opens today at 3:15pm
The demand for drugs and biosimilars is growing. The need to produce high concentrations of approved biotherapeutics in smaller and more flexible facilities has driven the development of increasingly sophisticated perfusion technologies. Furthermore, the advent of single-use products has accelerated production, minimized the risk of contamination, and requires less capital investment than traditional fed-batch culture. This technical workshop will discuss the challenges of developing and evaluating a perfusion process, and demonstrates how it can be successfully utilized as part of a single-use bioreactor system.